{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T00:17:27Z","timestamp":1783210647804,"version":"3.54.6"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medizinische Universit\u00e4t Wien","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jaci.2026.02.008","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T16:19:52Z","timestamp":1771604392000},"page":"269-277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Soluble Fc\u03b5RI is increased in advanced mastocytosis and acts as a negative regulator of mast cell expansion and activation"],"prefix":"10.1016","volume":"158","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6759-4662","authenticated-orcid":false,"given":"Gabriele","family":"Stefanzl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Kopanja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ivanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Greiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Hoermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Arock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsolt","family":"Sz\u00e9pfalusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang R.","family":"Sperr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Valent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2026.02.008_bib1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0065-2776(08)60879-2","article-title":"Cell surface structures on human basophils and mast cells: biochemical and functional characterization","volume":"52","author":"Valent","year":"1992","journal-title":"Adv Immunol"},{"key":"10.1016\/j.jaci.2026.02.008_bib2","first-page":"3","article-title":"Mast cells and basophils","volume":"16","author":"Schwartz","year":"2002","journal-title":"Clin Allergy Immunol"},{"key":"10.1016\/j.jaci.2026.02.008_bib3","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1182\/blood-2007-11-078097","article-title":"Mast cells and mastocytosis","volume":"112","author":"Metcalfe","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2026.02.008_bib4","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nm.2755","article-title":"IgE and mast cells in allergic disease","volume":"18","author":"Galli","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2026.02.008_bib5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1056\/NEJMra1409760","article-title":"Mast cells, mastocytosis, and related disorders","volume":"373","author":"Theoharides","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2026.02.008_bib6","doi-asserted-by":"crossref","first-page":"10743","DOI":"10.7150\/thno.46719","article-title":"Mast cells as a unique hematopoietic lineage and cell system: from Paul Ehrlich\u2019s visions to precision medicine concepts","volume":"10","author":"Valent","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.jaci.2026.02.008_bib7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev-immunol-071719-094903","article-title":"Mast cells in inflammation and disease: recent progress and ongoing concerns","volume":"38","author":"Galli","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2026.02.008_bib8","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev-pathmechdis-031521-042618","article-title":"New insights into the pathogenesis of mastocytosis: emerging concepts in diagnosis and therapy","volume":"18","author":"Valent","year":"2023","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.jaci.2026.02.008_bib9","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/ACI.0b013e3283036a90","article-title":"Understanding the mechanisms of anaphylaxis","volume":"8","author":"Peavy","year":"2008","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.02.008_bib10","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jaci.2009.08.035","article-title":"Mechanisms of mast cell signaling in anaphylaxis","volume":"124","author":"Metcalfe","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.02.008_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000315937","article-title":"Anaphylaxis: mechanisms of mast cell activation","volume":"95","author":"Kalesnikoff","year":"2010","journal-title":"Chem Immunol Allergy"},{"key":"10.1016\/j.jaci.2026.02.008_bib12","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/cea.12318","article-title":"Risk factors and management of severe life-threatening anaphylaxis in patients with clonal mast cell disorders","volume":"44","author":"Valent","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2026.02.008_bib13","first-page":"288","article-title":"Mastocytosis and allergic diseases","volume":"24","author":"Bonadonna","year":"2014","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaci.2026.02.008_bib14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.iac.2014.02.004","article-title":"Epidemiology, diagnosis, and treatment of Hymenoptera venom allergy in mastocytosis patients","volume":"34","author":"Niedoszytko","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2026.02.008_bib15","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1182\/blood-2006-06-028100","article-title":"Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with \u201cidiopathic\u201d anaphylaxis","volume":"110","author":"Akin","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2026.02.008_bib16","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jaci.2010.08.035","article-title":"Mast cell activation syndrome: proposed diagnostic criteria","volume":"126","author":"Akin","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.02.008_bib17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000328760","article-title":"Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal","volume":"157","author":"Valent","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2026.02.008_bib18","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaci.2020.06.035","article-title":"Heritable risk for severe anaphylaxis associated with increased \u03b1-tryptase\u2013encoding germline copy number at TPSAB1","volume":"147","author":"Lyons","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.02.008_bib19","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: a consensus proposal","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaci.2026.02.008_bib20","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","article-title":"Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria","volume":"37","author":"Valent","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jaci.2026.02.008_bib21","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1182\/blood-2016-09-731893","article-title":"Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts","volume":"129","author":"Valent","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2026.02.008_bib22","first-page":"54","article-title":"Mastocytosis (mast cell disease)","volume":"2","author":"Horny","year":"2008"},{"key":"10.1016\/j.jaci.2026.02.008_bib23","first-page":"62","article-title":"Mastocytosis","volume":"3","author":"Horny","year":"2017"},{"key":"10.1016\/j.jaci.2026.02.008_bib24","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000646","article-title":"Updated diagnostic criteria and classification of mast cell disorders: a consensus proposal","volume":"5","author":"Valent","year":"2021","journal-title":"Hemasphere"},{"key":"10.1016\/j.jaci.2026.02.008_bib25","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.jaci.2026.02.008_bib26","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1182\/blood-2009-02-205237","article-title":"Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors","volume":"113","author":"Lim","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2026.02.008_bib27","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1182\/blood-2009-05-220145","article-title":"Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies","volume":"114","author":"Pardanani","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2026.02.008_bib28","doi-asserted-by":"crossref","first-page":"e638","DOI":"10.1016\/S2352-3026(19)30166-8","article-title":"International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study","volume":"6","author":"Sperr","year":"2019","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jaci.2026.02.008_bib29","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1200\/JCO.19.00640","article-title":"MARS: mutation-adjusted risk score for advanced systemic mastocytosis","volume":"37","author":"Jawhar","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaci.2026.02.008_bib30","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1111\/all.14248","article-title":"Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification","volume":"75","author":"Trizuljak","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.02.008_bib31","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1016\/S2352-3026(20)30400-2","article-title":"Proposed global prognostic score for systemic mastocytosis: a retrospective prognostic modelling study","volume":"8","author":"Mu\u00f1oz-Gonz\u00e1lez","year":"2021","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jaci.2026.02.008_bib32","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.3390\/ijms22052684","article-title":"Mediator-related symptoms and anaphylaxis in children with mastocytosis","volume":"22","author":"Brockow","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaci.2026.02.008_bib33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10875-018-0506-y","article-title":"First identification of an inherited TPSAB1 quintuplication in a patient with clonal mast cell disease","volume":"38","author":"Sabato","year":"2018","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2026.02.008_bib34","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/ACI.0000000000000678","article-title":"Hymenoptera venom\u2013induced anaphylaxis and hereditary alpha-tryptasemia","volume":"20","author":"O\u2019Connell","year":"2020","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.02.008_bib35","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1182\/blood.2020006157","article-title":"Hereditary \u03b1 tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis","volume":"137","author":"Greiner","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2026.02.008_bib36","doi-asserted-by":"crossref","first-page":"9030","DOI":"10.3390\/ijms21239030","article-title":"Diagnosis, classification and management of mast cell activation syndromes (MCAS) in the era of personalized medicine","volume":"21","author":"Valent","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaci.2026.02.008_bib37","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/jlb.59.6.824","article-title":"Diamine oxidase\u2013gold ultrastructural localization of histamine in isolated human lung mast cells stimulated to undergo anaphylactic degranulation and recovery in vitro","volume":"59","author":"Dvorak","year":"1996","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jaci.2026.02.008_bib38","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1096\/fj.05-3999fje","article-title":"Allergen cleavage by effector cell\u2013derived proteases regulates allergic inflammation","volume":"20","author":"Rauter","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.jaci.2026.02.008_bib39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jaci.2007.08.015","article-title":"Mast cell\u2013derived proteases control allergic inflammation through cleavage of IgE","volume":"121","author":"Rauter","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.02.008_bib40","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/978-1-4419-9533-9_12","article-title":"Mast cell proteases as protective and inflammatory mediators","volume":"716","author":"Caughey","year":"2011","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jaci.2026.02.008_bib41","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.molimm.2014.02.017","article-title":"SHIP1 and the negative control of mast cell\/basophil activation by supra-optimal antigen concentrations","volume":"63","author":"Huber","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaci.2026.02.008_bib42","doi-asserted-by":"crossref","first-page":"709","DOI":"10.4049\/jimmunol.2100485","article-title":"Multistep IgE mast cell desensitization is a dose- and time-dependent process partially regulated by SHIP-1","volume":"210","author":"Adnan","year":"2023","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2026.02.008_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019098","article-title":"A soluble form of the high affinity IgE receptor, Fc-epsilon-RI, circulates in human serum","volume":"6","author":"Dehlink","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2026.02.008_bib44","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/all.13567","article-title":"The soluble isoform of human Fc\u03b5RI is an endogenous inhibitor of IgE-mediated mast cell responses","volume":"74","author":"Mo\u00f1ino-Romero","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.02.008_bib45","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1111\/all.13734","article-title":"Soluble Fc\u03b5RI: a biomarker for IgE-mediated diseases","volume":"74","author":"Mo\u00f1ino-Romero","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.02.008_bib46","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/j.jaip.2020.01.047","article-title":"Soluble Fc\u03b5RI, IgE, and tryptase as potential biomarkers of rapid desensitizations for platin IgE sensitized cancer patients","volume":"8","author":"Mo\u00f1ino-Romero","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2026.02.008_bib47","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1074-7613(01)00157-1","article-title":"Regulation of mast cell survival by IgE","volume":"14","author":"Asai","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.02.008_bib48","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nri914","article-title":"Regulation of mast-cell and basophil function and survival by IgE","volume":"2","author":"Kawakami","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2026.02.008_bib49","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1096\/fj.14-250894","article-title":"CD52 is a molecular target in advanced systemic mastocytosis","volume":"28","author":"Hoermann","year":"2014","journal-title":"FASEB J"},{"key":"10.1016\/j.jaci.2026.02.008_bib50","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1182\/blood-2013-10-534685","article-title":"A new human mast cell line expressing a functional IgE receptor converts to factor-independence and tumorigenicity by KIT D816V\u2013transfection","volume":"124","author":"Saleh","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2026.02.008_bib51","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0145-2126(88)90050-1","article-title":"Establishment of an immature mast cell line from a patient with mast cell leukemia","volume":"12","author":"Butterfield","year":"1988","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaci.2026.02.008_bib52","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1182\/blood-2005-07-3022","article-title":"PKC412 inhibits in vitro growth of neoplastic human mast cells expressing the D816V-mutated variant of KIT: comparison with AMN107, imatinib, and cladribine (2CdA) and evaluation of cooperative drug effects","volume":"107","author":"Gleixner","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2026.02.008_bib53","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0145-2126(85)90060-8","article-title":"A new leukemia cell line with Philadelphia chromosome characterized as basophil precursors","volume":"9","author":"Kishi","year":"1985","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaci.2026.02.008_bib54","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jaci.2022.07.018","article-title":"Expression and regulation of Siglec-6 (CD327) on human mast cells and basophils","volume":"151","author":"Smiljkovic","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.02.008_bib55","first-page":"355","article-title":"Antineoplastic efficacy profiles of avapritinib and nintedanib in KIT D816V+ systemic mastocytosis: a preclinical study","volume":"13","author":"Degenfeld-Schonburg","year":"2023","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.jaci.2026.02.008_bib56","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1096\/fj.10-158378","article-title":"A novel Fc\u03b5RI\u03b2-chain truncation regulates human mast cell proliferation and survival","volume":"24","author":"Cruse","year":"2010","journal-title":"FASEB J"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926000898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926000898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T23:41:01Z","timestamp":1783208461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674926000898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0091674926000898"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2026.02.008","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Soluble Fc\u03b5RI is increased in advanced mastocytosis and acts as a negative regulator of mast cell expansion and activation","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2026.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}